Recent lines of evidence, including ours, indicate the presence of pathological tau seeds in brain-derived EVs (BD-EVs) of AD transgenic mouse models [20–22] and AD brain patients [21, 23]. The gene discussed is MAPT; the disease is Alzheimer disease.